Skip to content
  1. Home
  2. Latest news
  3. Johnson & Johnson teams up with the Ad Council to cheer on diversity
Love Has No Labels Banner

Johnson & Johnson teams up with the Ad Council to cheer on diversity

This Valentine’s Day, the company is supporting the Love Has No Labels campaign to help spread the word about embracing equality, inclusion—and love.

You don’t need a foam finger or a felt pennant to show you’re a fan. A fan of love, that is.

Johnson & Johnson has been a fan of love for more than 130 years. Diversity, inclusion and equality are at the heart of everything we do—from our commitment to helping employees grow personally and professionally to our products and innovations that deliver care around the world.

This culture of belonging and open-mindedness dates back to our company Credo, which was written back in 1943 and guides our decision-making to this day.

So it was a no-brainer for us to team up recently with the Ad Council, as part of their Love Has No Labels campaign, to help turn the “kiss cam”—a fan favorite at sporting events—into a symbol for unbiased love at the 2017 NFL Pro Bowl in Orlando.

Check out the below video to watch the playful game day experiment in action.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.